Small business saturday, november 25. Vector illustration of small business saturday. Holiday ... [+] concept for banner, ...
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...
High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one <a target=_blank href= ...
Posters will be presented ... DARPins offer benefits to drug design over other currently available protein-based therapeutics. DARPin candidates can be radically simple, with a single DARPin unit ...
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported third quarter results and business highlights for the quarter ended September 30, 2024, including recent commercial ...
Clearly you can’t visit the sand planet of Arrakis and maybe you wouldn’t want to. It’s hot, it’s dry, and you can’t walk in ...
Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback